Artera’s prostate biopsy and breast cancer assays receive CE mark
Summary
Artera has secured CE marking under the EU IVDR for its ArteraAI Prostate Biopsy and Breast Cancer assays, expanding the company’s global reach.
Description
Artera has secured CE marking under the EU IVDR for its ArteraAI Prostate Biopsy and Breast Cancer assays, expanding the company’s global reach.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source